Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Helyx Industries SpA's 3-Year RORE % for the quarter that ended in Dec. 2025 was -24.81%.
The industry rank for Helyx Industries SpA's 3-Year RORE % or its related term are showing as below:
MIL:HLX's 3-Year RORE % is ranked worse than 63.67% of 1291
companies
in the Biotechnology industry
Industry Median: -11.44
vs MIL:HLX: -24.81
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Helyx Industries SpA 3-Year RORE % Related Terms
Helyx Industries SpA 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Helyx Industries SpA's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:HLX vs VRTX, REGN, ALNY: 3-Year RORE % Comparison
For the Biotechnology subindustry, Helyx Industries SpA's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helyx Industries SpA 3-Year RORE % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Helyx Industries SpA's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Helyx Industries SpA's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Helyx Industries SpA (MIL:HLX) has a 3-Year RORE % of -24.81 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Helyx Industries SpA and its competitors. According to the industry distribution chart, Helyx Industries SpA ranks #822 out of 1291 companies in the Biotechnology industry, placing it in the top 63.7%.
Is Helyx Industries SpA's 3-Year RORE % too high?
Helyx Industries SpA's current 3-Year RORE % is -24.81. Based on the distribution chart, Helyx Industries SpA ranks #822 out of 1291 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Helyx Industries SpA has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Helyx Industries SpA's 3-Year RORE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helyx Industries SpA ranks #822 out of 1291 companies for 3-Year RORE %. This places Helyx Industries SpA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Biotechnology company?
A good 3-Year RORE % depends on the Biotechnology industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Helyx Industries SpA and its competitors. Helyx Industries SpA's current 3-Year RORE % is -24.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helyx Industries SpA stock overvalued right now?
Based on GuruFocus' analysis, Helyx Industries SpA (MIL:HLX) is currently considered Possible Value Trap. The stock's GF Value™ is €3.48, compared to a current price of €0.70 — trading 79.8% below its estimated fair value. The current 3-Year RORE % is -24.81. Helyx Industries SpA's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Helyx Industries SpA (MIL:HLX), the current 3-Year RORE % is -24.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Helyx Industries SpA (MIL:HLX) Overvalued in 2026?
Based on GuruFocus' analysis, Helyx Industries SpA stock appears to be undervalued.
The current stock price of €0.70 is trading 79.8% below its estimated GF Value™ of €3.48.
GuruFocus considers Helyx Industries SpA to be Possible Value Trap.
Key valuation signals for MIL:HLX:
3-Year RORE %: -24.81
GF Value™: €3.48 vs. price of €0.70 (79.8% below fair value)
No single metric tells the full story. See the MIL:HLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Helyx Industries SpA is a healthcare biotech company focusing on genetics. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions.
62GF Score
Get the complete analysis for MIL:HLX
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HLX has been successfully added to your 
